Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2019 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

4 results

Results by year

Filters applied: . Clear all
Page 1
Tofacitinib in Acute Severe Ulcerative Colitis (TACOS): A Randomized Controlled Trial.
Singh A, Goyal MK, Midha V, Mahajan R, Kaur K, Gupta YK, Singh D, Bansal N, Kaur R, Kalra S, Goyal O, Mehta V, Sood A. Singh A, et al. Am J Gastroenterol. 2024 Jan 22. doi: 10.14309/ajg.0000000000002635. Online ahead of print. Am J Gastroenterol. 2024. PMID: 38131615
INTRODUCTION: Intravenous corticosteroids are the mainstay of treatment of patients hospitalized with acute severe ulcerative colitis (ASUC). However, 30%-40% of the patients are refractory to corticosteroids. We investigated whether addition of tofacitinib to corticostero …
INTRODUCTION: Intravenous corticosteroids are the mainstay of treatment of patients hospitalized with acute severe ulcerative colitis …
Tofacitinib Versus Oral Prednisolone for Induction of Remission in Moderately Active Ulcerative Colitis [ORCHID]: A Prospective, Open-Label, Randomized, Pilot Study.
Singh A, Midha V, Kaur K, Mahajan R, Singh D, Kaur R, Kohli A, Chawla A, Sood K, Bansal N, Sood A. Singh A, et al. J Crohns Colitis. 2024 Feb 26;18(2):300-307. doi: 10.1093/ecco-jcc/jjad153. J Crohns Colitis. 2024. PMID: 37656880 Clinical Trial.
We compared the efficacy and safety of tofacitinib and prednisolone for induction of remission in moderately active UC. METHODS: This was a single-centre, prospective, open-label, randomized, active-controlled pilot study. ...One patient each in the tofacitinib and prednis …
We compared the efficacy and safety of tofacitinib and prednisolone for induction of remission in moderately active UC. METHODS: This was a …
Diet and inflammatory bowel disease: The Asian Working Group guidelines.
Sood A, Ahuja V, Kedia S, Midha V, Mahajan R, Mehta V, Sudhakar R, Singh A, Kumar A, Puri AS, Tantry BV, Thapa BR, Goswami B, Behera BN, Ye BD, Bansal D, Desai D, Pai G, Yattoo GN, Makharia G, Wijewantha HS, Venkataraman J, Shenoy KT, Dwivedi M, Sahu MK, Bajaj M, Abdullah M, Singh N, Singh N, Abraham P, Khosla R, Tandon R, Misra SP, Nijhawan S, Sinha SK, Bopana S, Krishnaswamy S, Joshi S, Singh SP, Bhatia S, Gupta S, Bhatia S, Ghoshal UC. Sood A, et al. Indian J Gastroenterol. 2019 Jun;38(3):220-246. doi: 10.1007/s12664-019-00976-1. Epub 2019 Jul 27. Indian J Gastroenterol. 2019. PMID: 31352652 Free PMC article.
Efficacy of fecal microbiota therapy in steroid dependent ulcerative colitis: a real world intention-to-treat analysis.
Sood A, Mahajan R, Juyal G, Midha V, Grewal CS, Mehta V, Singh A, Joshi MC, Narang V, Kaur K, Sidhu H. Sood A, et al. Intest Res. 2019 Jan;17(1):78-86. doi: 10.5217/ir.2018.00089. Epub 2018 Nov 20. Intest Res. 2019. PMID: 30449078 Free PMC article.
We assessed the efficacy of FMT in a real-world setting involving steroid-dependent patients with UC. METHODS: This was a single-center prospective analysis of data from steroid-dependent patients with UC treated with FMT from September 2015 to September 2017 at the Day …
We assessed the efficacy of FMT in a real-world setting involving steroid-dependent patients with UC. METHODS: This was a single-center …